Process Validation of Sertraline Hydrochloride 50 mg tablets

Authors

  • Parixit Rohitbhai Prajapati Department of Quality Assurance Techniques, SSR Collage of Pharmacy, Silvassa, U. T. of Dadra & Nagar Haveli -396230
  • Deepika Natu Rathod Department of Quality Assurance Techniques, SSR College of Pharmacy, Silvassa, Sayli road, 396230
  • Vishalkumar Shashikant Modi Head of Department, Department of Pharmaceutical Chemistry, SSR College of Pharmacy, Sayli road, Silvassa-396230.
  • Tarasankar Basuri Department of Pharmaceutical Chemistry, SSR College of Pharmacy, Sayli road, silvassa-396230.

DOI:

https://doi.org/10.7439/ijpc.v6i9.3554

Abstract

The purpose of present research work wasto study Process Validation of Sertraline hydrochloride 50 mg tablet dosage form. As in a pharmaceutical product the quality cannot be directly incorporated or assured by in process and finished products inspections and testing rather it has to be incorporated in the manufacturing process itself. Process Validation helps in controlling all the parameters so that the finished product meets all the specifications and quality attributes. Various critical parameters involved in the process were identified with the help of process capability and thereby evaluating and challenging its lower and upper specifications. Three initial batches of same size, method, equipment and validation criteria were chosen. Other critical parameters involved in sifting, dry mixing, wet mixing, granulation, drying, sifting and sizing, lubrication, compression and coating stages were identified as per the Validation Master Plan. The outcome of the research work was that the process validation is providing the products that provide high degree of assurance that manufacturing process is producing products meeting its predetermined specifications and quality attributes.

Downloads

Download data is not yet available.

References

Alam M, Pharmaceutical Process Validation: An Overview, Journal of Advanced Pharmacy Education & Research, 2012; 2(4): 185-200.

Kruse N, EMA Guidance documents on process validation - where are we, Danish Health and Medicines Authority, 2014; 1-24.

Guidance for Industry: Process Validation: General Principles and Practices. U.S. Department of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER), Centre for Biologics Evaluation and Research (CBER), Centre for Veterinary Medicine (CVM), January 2011.

Morrison R, Process Validation: Practical Aspects of the

Redmond A, Calnan N and Neil S, The FDA

Shruthi N, Gupta N, Raghunandan H and Kashyap U, USFDA Guidelines on Process Validation - A Review, International Journal of PharmTech Research, 2014; 6(3): 920-923.

Nash R and Wachter A, Pharmaceutical Process Validation, Third Edition, Volume 129, Marcel Dekker Inc, 2003: 41- 44, 159

Katz P and Campbell C, FDA 2011 Process Validation Guidance: Process Validation Revisited, 2011: 3-12.

Jatto E and Okhamafe A, An Overview of Pharmaceutical Validation and Process Controls in Drug Development, Tropical Journal of Pharmaceutical Research, 2002; 1(2): 115-122.

Annex 3, Guidelines on good manufacturing practices: validation, Appendix 7: non-sterile process validation, WHO Expert Committee on Specifications for Pharmaceutical Preparations Forty-ninth report: 75-86.

Pluta P, FDA Lifecycle Approach to Process Validation - What, Why and How? Journal of Validation Technology, 2011; 1(1): 51-61.

Pharmaceutical Inspection Convention, PI-006-3, Validation Master Plan, Installation and Operational Qualification, Non-Sterile Process Validation Cleaning Validation, Pharmaceutical Inspection Co-operation Scheme, 2007: 5-16.

Downloads

Published

2016-09-30

Issue

Section

Research Articles

How to Cite

1.
Process Validation of Sertraline Hydrochloride 50 mg tablets. Int J of Pharm Chem [Internet]. 2016 Sep. 30 [cited 2026 Jan. 3];6(9):209-17. Available from: https://ssjournals.co.in/index.php/ijpc/article/view/3554